Beijing Chunlizhengda Medical Instruments Co., Ltd. (SHA:688236)

SHA:688236 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,797	1,140	1,266	957.19	1,736	690.29
Short-Term Investments	-	-	-	-	-	-0.31
Trading Asset Securities	-	745.8	832.02	767.73	-	-
Cash & Short-Term Investments	1,797	1,886	2,098	1,725	1,736	689.97
Cash Growth	-8.39%	-10.14%	21.65%	-0.67%	151.68%	47.46%
Accounts Receivable	456.47	378.71	441.72	767.39	527.79	371.08
Other Receivables	0.31	17.46	18.61	13.5	4.49	0.27
Receivables	456.78	396.17	460.33	780.89	532.28	371.34
Inventory	561.22	550.84	434.49	259.79	159.68	168.61
Prepaid Expenses	-	-	-	-	0.01	-
Other Current Assets	33.91	7.89	12.16	13.49	19.3	22.06
Total Current Assets	2,849	2,840	3,005	2,779	2,448	1,252
Property, Plant & Equipment	464.72	468.8	465.13	465.27	394.75	164.85
Goodwill	-	-	13.36	-	-	-
Other Intangible Assets	126.59	127.57	136.27	138.17	131.97	101.49
Long-Term Deferred Tax Assets	26.8	26.11	27.63	25.76	22.88	21.55
Long-Term Deferred Charges	-	-	-	-	0.13	0.35
Other Long-Term Assets	6.38	2.77	1.8	1.48	2.16	1.61
Total Assets	3,474	3,466	3,650	3,410	3,000	1,542
Accounts Payable	198.9	227.85	225.5	237.79	77.66	90.29
Accrued Expenses	50.5	74.17	149.71	120.81	122.48	95.12
Current Portion of Leases	0.69	0.68	1.22	0.69	1.23	1.18
Current Income Taxes Payable	9.14	0.94	12.13	10.88	10.16	10.43
Current Unearned Revenue	116.32	128.56	149.56	85.68	59.54	82.88
Other Current Liabilities	121.65	114.55	138.55	139.96	168.54	88.95
Total Current Liabilities	497.2	546.75	676.67	595.8	439.62	368.85
Long-Term Leases	0.15	0.18	0.53	0.63	-	0.67
Long-Term Unearned Revenue	85.82	86.75	83.79	85.76	85.56	88.17
Long-Term Deferred Tax Liabilities	10.99	10.71	9.33	7.88	5.4	4.57
Total Liabilities	594.16	644.39	770.33	690.07	530.58	462.26
Common Stock	383.57	383.57	383.57	384.28	384.28	345.85
Additional Paid-In Capital	-	1,045	1,045	1,051	1,051	22.53
Retained Earnings	1,462	1,404	1,449	1,291	1,034	711.21
Treasury Stock	-12.02	-12.02	-	-7.14	-	-
Comprehensive Income & Other	1,045	-	-	-	-	-
Total Common Equity	2,878	2,820	2,877	2,720	2,469	1,080
Minority Interest	1.4	1.44	1.77	-	-	-
Shareholders' Equity	2,879	2,821	2,879	2,720	2,469	1,080
Total Liabilities & Equity	3,474	3,466	3,650	3,410	3,000	1,542
Total Debt	0.84	0.87	1.75	1.31	1.23	1.85
Net Cash (Debt)	1,796	1,885	2,097	1,724	1,735	688.12
Net Cash Growth	-8.35%	-10.11%	21.64%	-0.67%	152.17%	47.06%
Net Cash Per Share	4.77	4.98	5.43	4.48	5.01	1.99
Filing Date Shares Outstanding	382.7	382.7	383.57	383.57	384.28	345.85
Total Common Shares Outstanding	382.7	382.7	383.57	383.57	384.28	345.85
Working Capital	2,352	2,294	2,329	2,183	2,008	883.15
Book Value Per Share	7.52	7.37	7.50	7.09	6.43	3.12
Tangible Book Value	2,751	2,692	2,728	2,582	2,337	978.1
Tangible Book Value Per Share	7.19	7.04	7.11	6.73	6.08	2.83
Buildings	-	223.09	223.04	184.58	31.31	31.31
Machinery	-	224.08	200.27	179.96	146.51	130.57
Construction In Progress	-	156.78	150.14	185.1	281.56	55.07

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.